Pieter Kroese Replaces Mark Koeniguer as CEO of ScreenPoint

ScreenPoint Medical, a leading innovator in breast cancer detection technology, is undergoing a significant leadership transition as CEO Mark Koeniguer steps down after two years of dedicated service. The company’s Board of Directors has unanimously appointed Pieter Kroese as the new CEO, effective April 25, marking a new chapter in ScreenPoint’s journey of innovation and growth.

Kroese brings a wealth of experience and expertise to his new role, having served as Chief Operating Officer (COO) for the past five years. During his tenure, Kroese played a pivotal role in driving the company’s growth trajectory, spearheading strategic initiatives and operational excellence.

While ScreenPoint did not provide specific reasons for Koeniguer’s departure, the company expressed its gratitude for his contributions and wished him every success in his future endeavors. Koeniguer’s leadership has undoubtedly played a significant role in ScreenPoint’s advancements, and his legacy will continue to resonate within the company.

As ScreenPoint transitions to a new era under Kroese’s leadership, the company remains committed to its mission of revolutionizing breast cancer detection through cutting-edge technology. With Kroese at the helm, ScreenPoint is poised to build upon its past successes and drive continued innovation in the field of medical imaging.

ScreenPoint extends a warm welcome to Pieter Kroese as CEO and looks forward to embarking on this exciting new chapter together, further solidifying its position as a leader in breast cancer detection technology.

Have you read?
Best countries for hiring freelancers.
The Evolving Landscape of the C-Suite: Navigating Complexity with Precision. 
Petr Aven: Harmonizing Economics, Philanthropy, and Art.
Your Pizza Perspective: 6 Things African and Western Leaders Can Learn From Each Other.
Recovering from Grief with Dr. Lenore Matthew, a Young Widow and Intuitive Academic.